Reply to N. Rompoti et al.
Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.
Imke
I
Satzger
Annette
A
Degen
Hiba
H
Asper
Alexander
A
Kapp
Axel
A
Hauschild
Ralf
R
Gutzmer
D003877:Dermatitis, Contact / Q000209:etiology*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D010091:Oximes / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D011832:Radiation Injuries / Q000209:etiology*; D013449:Sulfonamides / Q000009:adverse effects*
D007093:Imidazoles; D007211:Indoles; D010091:Oximes; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D048493:Proto-Oncogene Proteins B-raf